has received an Innovative Technology contract from Vizient Inc. the largest member-driven health care performance improvement company in the United States.
Vizient awards such contracts to technologies that “identify breakthrough solutions that can improve patient care or reduce the risk of harm to patients or providers, while simultaneously raising the standard of patient care and safety.”
Based on the recommendation of hospital experts in haemodynamics, Deltex’s focus, Vizient has ordered the CardioQ-EDM+, a device that measures blood flow velocity in the central circulation in real time.
The validation of receiving this contract builds on Deltex’s reputation as “the only company in the enhanced haemodynamic space to have built a robust evidence base demonstrating both the clinical and economic benefits of its core technology.”
CEO of Deltex Medical, Andy Mears commented, “The Board is appreciative of the award of this prestigious Vizient Innovative Technology contract, which recognises the important role the CardioQ-EDM+ plays in improving patient safety during and after surgery.”
For more news and updates from Deltex Medical Group:
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
The UK intellectual property investment group believes this particular partnership will flourish, in part, thanks to UTEQ’s prime location in the “high-tech zone” of Queretaro, cultivating the region’s technology and innovation scene.
SP Angel research note on commodities and miners, featuring: Condor Gold (CNR LN) – Progress report on permitting IronRidge Resources* (IRR LN) – Zaranou license high-grade gold Petropavlovsk (POG LN) – H1 2019 production results Shanta Gold (SHG LN) – Ilunga underground mine achieved commercial production
BP is to expand its Brazilian biofuels business by combining it with a larger rival in a move that it said would help the transition to lower-carbon energy, British Airways is launching legal action to block its pilots from staging a potentially disruptive walkout this summer
The company shared that approximately 67% of these revenues were derived from recurring contracts, especially the “transformational” acquisition of PeopleFluent back in May 2018.
SP Angel research note on commodities and miners, featuring: Galantas Gold (GAL LN) – Kearney Vein intersected on 1060 level of the Omagh mine Petra Diamonds (PDL LN) – Meets production guidance for year to 30th June Serabi Gold (SRB LN) – Production guidance maintained following Q2 results Tri-Star Resources* (TSTR LN) – SPMP report first antimony metal production